Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × tremelimumab × Clear all

Phase

Status

Completed 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Hepatocellular 22 Liver Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Pancreatic Neoplasms 2 Cholangiocarcinoma 2 Urinary Bladder Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Lung Neoplasms 1 Liver Cirrhosis 1 Endometrial Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma 1

Interventions

pembrolizumab 46 Specimen Handling 30 Magnetic Resonance Spectroscopy 27 Biopsy 26 Radiosurgery 19 Gemcitabine 14 Nivolumab 13 Cisplatin 13 Paclitaxel 11 Carboplatin 11 Cyclophosphamide 10 Taxes 9 Pemetrexed 9 Leucovorin 9 Irinotecan 9 Fluorouracil 9 Capecitabine 9 Oxaliplatin 8 Drug Therapy 8 Doxorubicin 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Radiotherapy 7 olaparib 6 cemiplimab 6 abemaciclib 6 Standard of Care 6 Folfox protocol 6 Docetaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02029001 2025-08-07

MOST plus

Centre Leon Berard

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡